Global venture capital firm Bessemer Venture Partners has entered the specialized healthcare sector by leading a ₹125 crore Series A investment in Pluro Fertility and IVF, valuing the startup at ₹1,000 crore. This move reflects growing investor interest in single-speciality healthcare platforms, a strategy Bessemer previously pursued with Nephroplus in 2013.

Founded in 2025 by experienced doctors Dr. Jaydeep Tank, Dr. Parikshit Tank, and Dr. Bhaskar Shah, Pluro operates a unique clinical partnership model that collaborates with independent IVF specialists nationwide. The platform manages all non-clinical operations—including practice management, technology integration, regulatory compliance, and marketing—while offering equity participation to partners. Pluro plans to establish 25 fertility centres across India by March 2026, targeting specialists with at least 10 years of experience, and aims for over 100 clinics within three years. The funding will support network expansion, technology upgrades, and advanced reproductive science capabilities.

Despite competition from established chains like Indira IVF, Nova IVF Fertility, Apollo Fertility, Fortis La Femme, and ART Fertility Clinics, Dr. Jaydeep Tank emphasized that significant unmet demand exists for differentiated, technology-driven care. With only 10% of India’s ~6,000 IVF clinics part of organized networks, Bessemer’s Nithin Kaimal highlighted the vast opportunity in Tier II, III, and IV cities, describing the market as “underserved” with strong secular growth potential.

The round also attracted prominent angel investors, including Vikram Chhatwal (MediAssist), Dharmil Sheth and Hardik Dedhia (PharmEasy), Salil Musale (Astarc Ventures), Shalibhadra Shah and Niket Shah (Motilal Oswal), and Karan Kapur (K Hospitality). Notably, co-founder Dr. Bhaskar Shah is a leading cardiologist and father of PharmEasy co-founder Siddharth Shah.

India’s IVF market, valued at $864.6 million in 2024 per IMARC Group, is projected to reach $3.4 billion by 2033, growing at a 15.4% CAGR—driven by rising infertility awareness, delayed parenthood, technological advancements, and medical tourism.